Written Question · S2W-32494 · Session 2
Whether it will review and evaluate the impact of Prevenar on pneumococcal immunisation and, if so, when it will do so.
The question
To ask the Scottish Executive whether it will review and evaluate the impact of Prevenar on pneumococcal immunisation and, if so, when it will do so.
The answer
Health Protection Scotland is monitoring the incidence of invasivepneumococcal disease in children and adults to detect any reductions in its occurrence.It will then evaluate the impact of the introduction of Prevenar into the routinechildhood immunisation schedule and the current catch-up campaign.
In the Official Report
No contribution in the Official Report cites S2W-32494 by reference.